HHS Allows Specialty Pharmacies to Sell Six Unproven Peptides Despite FDA Safety Concerns
GeneralUS Health Secretary RFK Jr. has implemented a policy permitting compounding pharmacies to produce and sell six peptides popular in the MAHA movement, overriding FDA objections about their safety and efficacy.
